Will these bold bets pay off for Neil Woodford?

Roland Head takes a look at two of Neil Woodford’s top growth stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Star fund manager Neil Woodford is known for his big and successful bets on FTSE 100 stocks such as British American Tobacco and AstraZeneca. But he’s also a big fan of smaller, more speculative firms.

Today I’m going to take a look at two smaller stocks which have each grown to become top 20 holdings in Mr Woodford’s flagship Equity Income Fund. In both cases, Woodford Funds is also the largest institutional shareholder in each firm.

Too clever by half?

Mr Woodford is known for investing in small pharmaceutical, biotech and technology stocks. His team is able to research these fairly effectively in the UK. However, the US market for such firms is many times larger. That may be one reason why he has invested heavily in portfolio firm Allied Minds (LSE: ALM).

This firm invests in life science and technology start-ups in North America, with the aim of turning academic discoveries into commercial products. Investors in the company hope that this portfolio approach — combined with skilled research — will result in Allied striking gold.

The payback for this patient approach is the potential for a one-off windfall or lucrative long-term licensing revenues, such as from a new medicine. The risk, of course, is that this may never happen.

So far, Allied hasn’t managed to generate any cash for shareholders. The company has no revenue and is expected to report a loss of $88.7m for 2016.

One sign of hope is that the group’s founder and CEO, Chris Silva, has recently stepped down. He’s been replaced by Jill Smith whose appointment is intended to “accelerate commercial development across the portfolio.”

Ms Smith may succeed, but Allied remains highly speculative. If you’re tempted to follow Mr Woodford’s lead, it’s worth remembering that this stock only accounts for 1.83% of the Woodford Equity Income fund. I’d display similar caution if I was to invest myself.

This disruptive business could change everything

Woodford Funds is the largest shareholder of online estate agent Purplebricks Group (LSE: PURP). I’d imagine the holdings are now showing significant profits as Purplebricks’ stock has doubled in value over the last year.

There’s no doubt in my mind that the business model works and is gaining market share fast. Sales rose by 159% to £18.7m during the first half of the current year, while gross profit rose by 153% to £10.2m.

A UK gross profit margin of 55% suggests to me that the Purplebricks’ UK operations could soon start to generate meaningful profits. The risk is that the shares are already valued to reflect this growth potential.

A net loss of £9m is expected this year, as the firm continues to expand into new markets. But a profit of £1.14m is expected for 2017/18. That puts it on a forecast P/E of 165.

I’d normally run a mile from such an ambitious valuation. But Purplebricks is expanding fast and claims to have 67% of the UK online estate agency market. The group has also just raised £50m to fund a move into the much larger US market.

This stock could double or triple again. But it could also collapse. There’s no way to know. For me this is too speculative. But growth investors should probably continue to hold.

Roland Head has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Down 29%, should I buy Palantir for my Stocks and Shares ISA?

Palantir Technologies has lost over a quarter of its value in the past few months. Does this make it a…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Selling for £1, are Lloyds shares still a bargain?

Lloyds shares sold for pennies for many years -- but now cost a pound. Our writer sees some strengths in…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How much could spending just £5 a day on UK shares earn in passive income?

Sticking to UK shares in well-known companies, our writer shows how £5 a day could be used to target over…

Read more »

Dominos delivery man on skateboard holding pizza boxes
Investing Articles

Think you’re too young for a SIPP? Think again!

Is a SIPP something best left to later in working life? Not at all, according to this writer -- and…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

These 5 FTSE 100 shares all offer dividend yields well above average!

Christopher Ruane gives the lowdown on a handful of FTSE 100 shares, all yielding considerably higher than the index, that…

Read more »

Investing Articles

How to turn a Stocks and Shares ISA into £10k of annual passive income

Mark Hartley outlines a simple method of achieving a stable passive income stream from a Stocks and Shares ISA without…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 useful lessons from Warren Buffett for an investor over 40

Can Warren Buffett's long-term approach to investing still work for someone in middle age, or older? Christopher Ruane believes it…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

This UK growth share’s already doubled this year. I reckon it might just be getting going!

This UK growth share has more than doubled in a matter of weeks. Our writer thinks the market may be…

Read more »